Sort by
Keyphrases
Teratoma
100%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
100%
Pluripotent Stem Cells
100%
Stem Cell-derived
25%
Octamer-binding Transcription Factor 4 (OCT4)
16%
Conditioned Medium
16%
Neural Stem Cells
16%
Neural Precursor Cells
16%
Transplantation Therapy
16%
Cell Death
8%
Cell-to-cell
8%
Cell Culture
8%
Cell-based
8%
Expression Level
8%
Cyclin D1 (CCND1)
8%
Transplantation
8%
Matrix metalloproteinase-9 (MMP-9)
8%
Cardiovascular Disease
8%
Diabetes Disease
8%
Stem Cell Transplantation
8%
Matrix metalloproteinase-2 (MMP-2)
8%
Clinical Application
8%
Parkinson's Disease
8%
Cleaved caspase-3
8%
TIMP-2
8%
Cell Source
8%
Associated Risk
8%
DNA Damage Response
8%
Pluripotent
8%
Ablating
8%
Teratoma Formation
8%
Pharmacology, Toxicology and Pharmaceutical Science
Tissue Inhibitor of Metalloproteinase
100%
Teratoma
100%
Disease
25%
Cell Culture
25%
Tissue Inhibitor of Metalloproteinase 1
25%
Gelatinase B
25%
Caspase 3
25%
Gelatinase A
25%
Cyclin D1
25%
Parkinson's Disease
25%
Tissue Inhibitor of Metalloproteinase 2
25%
Cardiovascular Disease
25%
Medicine and Dentistry
Dentigerous Cyst
100%
Pluripotent Stem Cell
100%
Metalloprotease Inhibitor
100%
Neural Precursor Cells
15%
Neural Stem Cell
15%
Cell Death
7%
Disease
7%
Diabetes
7%
Cell Culture
7%
In Vitro
7%
Gelatinase B
7%
Cardiovascular Disease
7%
Stem Cell Therapy
7%
Gelatinase A
7%
Tissue Inhibitor of Metalloproteinase 1
7%
Caspase 3
7%
Tissue Inhibitor of Metalloproteinase 2
7%
Cyclin D1
7%
Parkinson's Disease
7%
DNA Damage Response
7%
Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
Teratoma
100%
Metalloprotease Inhibitor
100%
Precursor
14%
Cell Culture
7%
Cell Death
7%
Gelatinase B
7%
MMP9
7%
Caspase 3
7%
Cyclin D1
7%
Stem Cell Transplantation
7%
Gelatinase A
7%
MMP2
7%
DNA Damage Response
7%
Neuroscience
Stem Cell
100%
Metalloprotease Inhibitor
100%
Neural Stem Cell
25%
In Vivo
8%
In Vitro
8%
Cell Death
8%
Parkinson's Disease
8%
Caspase 3
8%
MMP2
8%
Cell Culture
8%
MMP9
8%
Cyclin D1
8%
DNA Damage Response
8%